Page 41 - Read Online
P. 41

Ryan et al. J Transl Genet Genom. 2025;9:48-61             Journal of Translational
               DOI: 10.20517/jtgg.2024.87
                                                                          Genetics and Genomics




               Original Article                                                              Open Access



               Investigating lysosomal dysfunction in Fabry
               disease using induced pluripotent stem cell-derived

               podocytes

                                                        1
                                          1
                            1
                                                                               2
                                                                                                   3
                                                                    1
               Caitlin R. Ryan , Andrea F. Wise , Elisha Tindoy , Shoni Bruell , Maria Fuller , Kathleen M. Nicholls ,
               Sharon D. Ricardo 1
               1
                Department of Pharmacology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria 3800, Australia.
               2
                Genetics and Molecular Pathology, South Australia Pathology at Women's and Children's Hospital and Adelaide Medical School
               and School of Biological Sciences, University of Adelaide, Adelaide, SA 5006, Australia.
               3
                Department of Nephrology, The Royal Melbourne Hospital and Department of Medicine (RMH), University of Melbourne,
               Parkville 3000, Australia.
               Correspondence to: Prof. Sharon D. Ricardo, Department of Pharmacology, Biomedicine Discovery Institute, Monash University,
               9 Ancora Imparo Way, Clayton, Victoria 3800, Australia. E-mail: sharon.ricardo@monash.edu
               How to cite this article: Ryan CR, Wise AF, Tindoy E, Bruell S, Fuller M, Nicholls KM, Ricardo SD. Investigating lysosomal
               dysfunction in Fabry disease using induced pluripotent stem cell-derived podocytes. J Transl Genet Genom. 2025;9:48-61. https:/
               /dx.doi.org/10.20517/jtgg.2024.87
               Received: 25 Oct 2024  First Decision: 20 Jan 2025  Revised: 3 Feb 2025  Accepted: 12 Feb 2025  Published: 26 Feb 2025

               Academic Editor: Sanjay Gupta  Copy Editor: Fangling Lan  Production Editor: Fangling Lan

               Abstract
               Aims: This study used induced pluripotent stem cell-derived podocytes from a Fabry disease (FD) patient carrying
               the p.Met284Thr pathogenic variant as an in vitro model to investigate lysosomal abnormalities driving cell
               pathology. Proteomic analysis was used to assess changes in lysosomal protein abundance in FD podocytes
               compared to controls. Additionally, temporal changes in lysosome number in FD podocytes were analyzed using
               automated live-cell imaging.

               Methods: Label-free mass spectrometry proteomics was performed on FD podocytes at day 10 of differentiation
               compared to controls. For live-cell imaging, cultured podocytes were transfected with CellLight Lysosomes-GFP
               and Plasma Membrane-CFP, and then visualized and quantified on days 10 and 20 post-differentiation using a
               Perkin Elmer Phenix High Content Screening Microscope.

               Results: Proteomic analysis showed dysregulation of glycosphingolipid metabolism proteins, including decreased
               galactosidase alpha (GLA; P < 0.01) and increased galactosylceramidase and glucosylceramidase (P < 0.01) in FD





                           © The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution 4.0
                           International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing,
                           adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as
               long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and
               indicate if changes were made.

                                                                                        www.oaepublish.com/jtgg
   36   37   38   39   40   41   42   43   44   45   46